What this domain asks
Risk that medicinal-product, device, substance, pack, presentation, identifier, label, and artwork data is inconsistent across source systems, submissions, authority databases, markets, safety processes, and supply operations.
The domain should retain its own evidence, decision owner, materiality criteria, exception path, and consequence even when it shares organization identity, workflow, or technology with adjacent domains. Aggregation can support oversight; it should not erase the evidence behind different risks or operating outcomes.
Buyer questions
- Which system owns each product, substance, organization, referential, packaging, identifier, and labeling data element?
- How are controlled vocabularies, terminology versions, translations, and authority identifiers governed?
- Can one approved safety or manufacturing change identify affected core labels, local labels, artwork, registrations, dossiers, packs, and inventory?
- How does the platform reconcile authority-held data with internal master data and document content?
- Which IDMP, SPOR, xEVMPD, UDI, SPL, and electronic product-information processes are supported, at which implementation phase?
- Can users trace every published or submitted value to its source, approval, effective date, and change history?
Mapped workflows
Change Control
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for change control within this domain.
Design Controls And Product Traceability
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for design controls and product traceability within this domain.
Regulatory Product And Registration Data
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for regulatory product and registration data within this domain.
Regulatory Activity And Commitment Tracking
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for regulatory activity and commitment tracking within this domain.
Submission Planning And Dossier Management
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for submission planning and dossier management within this domain.
Labeling And Structured Product Data
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for labeling and structured product data within this domain.
Health-Authority Correspondence
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for health-authority correspondence within this domain.
Authority context
EU MDR
The MDR establishes rules for placing medical devices on the EU market and covers economic operators, conformity assessment, quality systems, clinical evidence, technical documentation, UDI, registration, vigilance, post-market surveillance, and market surveillance.
EU IVDR
The IVDR establishes rules for in vitro diagnostic devices, including classification, conformity assessment, quality systems, performance evidence, technical documentation, UDI, registration, vigilance, post-market surveillance, and performance studies.
eCTD v4.0
eCTD v4.0 defines a harmonised structure and exchange model for regulatory submissions, with regional controlled vocabularies, module-one requirements, validation criteria, transmission specifications, and implementation timelines maintained by authorities.
ISO IDMP
The ISO IDMP family standardizes the identification and description of substances, dose forms and routes, units of measurement, regulated pharmaceutical products, and regulated medicinal products. EMA is implementing these concepts through substance, product, organization, and referential master-data services.
Relevant operating models
- Integrated Quality And Regulatory Platform
- Enterprise Regulatory Information Management Suite
- Regulatory Submissions And Publishing Platform
- Medical-Device Regulatory Information Management
Evidence boundary
RegQuality Review is not a regulator, certification body, law firm, or validation authority. Its records support research and decision review; they do not establish compliance for an organization, system, release, configuration, or intended use. A provider's documented capability can identify a research candidate but cannot establish buyer-specific adequacy for this domain.